AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 277: E126-E134, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galassetti, P.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galassetti, P.
Right arrow Articles by Cherrington, A. D.
Vol. 277, Issue 1, E126-E134, July 1999

A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs

Pietro Galassetti, Chang An Chu, Doss W. Neal, George W. Reed, David H. Wasserman, and Alan D. Cherrington

Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232-0615

We investigated whether a negative arterial-portal venous (a-pv) glucose gradient, or "portal signal," can increase net hepatic glucose uptake (NHGU) and decrease muscle glucose uptake at euglycemia as it does at hyperglycemia. Twenty 42-h fasted dogs were studied during a basal and two 120-min euglycemic periods (period I and period II). Glucagon was maintained at basal levels, and insulin was raised 3-fold (3×Ins, n = 10) or 15-fold (15×Ins, n = 10). During period I, dogs received glucose only peripherally. During period II, one-half of the dogs continued the peripheral infusion; the other one-half received glucose intraportally (4 mg · kg-1 · min-1 and reduced peripheral glucose infusion). A negative a-pv glucose gradient was present during intraportal glucose infusion. All 3×Ins and 15×Ins dogs had similar NHGU in period I. In period II, it was 2.1 ± 0.3 (3×Ins) and 2.5 (15×Ins) mg · kg-1 · min-1 greater in the presence than in the absence of the portal signal (P < 0.001). The net glucose fractional extraction data paralleled NHGU. In 3×Ins, but not in 15×Ins, whole body nonhepatic glucose uptake was lower in the presence of the portal signal than in its absence. In conclusion, in hyperinsulinemic, but not hyperglycemic conditions, the portal signal is effective in activating NHGU. The inhibition of nonhepatic glucose uptake, on the other hand, is minimal under euglycemic as opposed to hyperglycemic conditions.

liver; skeletal muscle


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Moore, C. A. DiCostanzo, M. S. Smith, B. Farmer, T. D. Rodewald, D. W. Neal, P. E. Williams, and A. D. Cherrington
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E768 - E777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Z. An, C. A. DiCostanzo, M. C. Moore, D. S. Edgerton, D. P. Dardevet, D. W. Neal, and A. D. Cherrington
Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E300 - E306.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Fukaya, A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, H. Yamamoto, Y. Taketani, T. Doi, and E. Takeda
Mechanism of rapid-phase insulin response to elevation of portal glucose concentration
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E515 - E522.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. A. DiCostanzo, D. P. Dardevet, D. W. Neal, M. Lautz, E. Allen, W. Snead, and A. D. Cherrington
Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E9 - E16.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Fery, L. Tappy, J. Deviere, and E. O. Balasse
Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E176 - E183.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, D. B. Lacy, Y. Zhang, S.-S. Chen, and O. P. McGuinness
Impact of chronic fructose infusion on hepatic metabolism during TPN administration
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1151 - E1158.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza
Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza
Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity
Diabetes, June 1, 2001; 50(6): 1351 - 1362.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Galassetti, Y. Koyama, R. H. Coker, D. B. Lacy, A. D. Cherrington, and D. H. Wasserman
Role of a negative arterial-portal venous glucose gradient in the postexercise state
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1038 - E1045.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online